Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial

Journal: Journal of Experimental Medicine

Published: 2020-09-07

DOI: 10.1084/jem.20191712

Affiliations: 6

Authors: 24

Go to article
Institutions Share
Stanford University, United States of America (USA) 0.88
University of Alberta (U of A), Canada 0.04
Adaptive Biotechnologies LLC, United States of America (USA) 0.04
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA) 0.04